Article | May 6, 2024

The ROI Of Patient Centricity: Faster Recruiting, More Diverse Study Populations, And Engaged Trial Participants

Source: IQVIA Research & Development Solutions
GettyImages-639668490 patient

In the past, patient recruitment for clinical trials followed a simpler path due to the absence of digital tools. With limited channels available, sponsors relied on traditional methods like print media, posters, cold calls, and referrals from healthcare providers. However, in today's digitally interconnected world, potential trial participants from diverse backgrounds navigate a vast array of online platforms effortlessly. With smartphones, social media, and tailored apps offering swift communication and personalized experiences, modern candidates expect quick responses, tailored interactions, and above all, acknowledgment of their perspectives—a crucial aspect in optimizing recruitment efforts.

At IQVIA, we drive success by prioritizing three core objectives: motivating patients, engaging sites, and personalizing solutions. These principles are now indispensable, demanding profound subject matter expertise and extensive capabilities.

Embracing patient centricity isn't just ethically imperative—it's pivotal for fostering greater inclusion among traditionally marginalized groups, fortifying clinical trials, and ultimately, improving healthcare outcomes. Join us in our commitment to revolutionizing clinical research by prioritizing patient needs, empowering research sites, and tailoring solutions for optimal results.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

IQVIA Research & Development Solutions